March 3, 2026Open Access

Epigenetic Regulation of Immune Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Key Points

Chronic prostatitis/chronic pelvic pain syndrome shows impaired il-10-mediated immune regulation, indicating significant immune dysfunction.
Inhibition of dna methylation restored il-10 responses, demonstrating a notable therapeutic potential with a promising outcome.
Assessment using pharmacologic interventions highlighted the role of demethylation therapy in alleviating pain effectively.
Results suggest that targeting epigenetic pathways may lead to novel treatments for chronic pelvic pain syndromes.

Abstract

CP/CPPS is associated with widespread epigenetic reprogramming of immune regulatory genes leading to impaired IL-10-mediated immune regulation. Pharmacologic inhibition of DNA methylation restored IL-10 responses and alleviated pain in vivo, supporting demethylation therapy as a potential strategy for treating chronic prostatic inflammation and pelvic pain.

Epigenetic Regulation of Immune Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Key Points

Abstract

Cite This Study